| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/08/1999 | WO1998009990A8 Fungal antigens and process for producing the same |
| 04/08/1999 | WO1998002455A3 Transcriptional intermediary factor-2 (tfif2) |
| 04/08/1999 | DE19844502A1 Agent for controlling cell growth |
| 04/08/1999 | CA2305809A1 Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis |
| 04/08/1999 | CA2305781A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | CA2305714A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
| 04/08/1999 | CA2305681A1 Apoptosis-related compounds and their use |
| 04/08/1999 | CA2305678A1 Protein involved in abscisic acid signalling |
| 04/08/1999 | CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | CA2305011A1 Isoforms of the human vitamin d receptor |
| 04/08/1999 | CA2304954A1 Killer t cell receptor recognizing human immunodeficiency virus |
| 04/08/1999 | CA2304931A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | CA2304814A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304665A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/08/1999 | CA2304508A1 Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors |
| 04/08/1999 | CA2304484A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| 04/08/1999 | CA2304366A1 Nepovirus resistance in grapevine |
| 04/08/1999 | CA2304209A1 Ras-binding protein (pre1) |
| 04/08/1999 | CA2303401A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | CA2295966A1 Gene promoter sequences and uses thereof |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/08/1999 | CA2213680A1 Nucleotide sequences and protein sequences |
| 04/08/1999 | CA2212606A1 A target for pre-symptomatic detection, control and prevention of multiple sclerosis in humans |
| 04/07/1999 | EP0907080A1 Method for assaying antigen relating to mental stress disorders |
| 04/07/1999 | EP0906958A2 Staphylococcus peptidyl-tRNA hydrolase (Pth) |
| 04/07/1999 | EP0906957A2 Lgt polypeptide |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906954A1 Amino-terminal truncated c-c chemokines as chemokine antagonist |
| 04/07/1999 | EP0906953A1 Allelic variant of human stat3 |
| 04/07/1999 | EP0906919A2 Novel integrin-binding peptides |
| 04/07/1999 | EP0906918A2 Process for production of insulin precursors having correctly linked cystein bridges |
| 04/07/1999 | EP0906669A1 Method and apparatus for data transmission using multiple transmit antennas |
| 04/07/1999 | EP0906577A1 Screening compounds for the ability to alter the production of amyloid-beta peptide |
| 04/07/1999 | EP0906576A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 04/07/1999 | EP0906571A1 Labelling and selection of molecules |
| 04/07/1999 | EP0906448A1 Methods for the diagnosis and prognosis of cancer |
| 04/07/1999 | EP0906444A1 Genetically transfected human dendritic cells, their production and use, preferably as vaccines |
| 04/07/1999 | EP0906442A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906439A1 Polycistronic expression plasmid for tumor-rejection |
| 04/07/1999 | EP0906427A1 Characterization of transfer factors and methods of use |
| 04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 04/07/1999 | EP0906425A2 Vasoactive amine binding molecules |
| 04/07/1999 | EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr] |
| 04/07/1999 | EP0906423A1 Metastasis-associated antigen and antibodies thereto |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
| 04/07/1999 | EP0906418A1 Methods and compositions for cellular and metabolic engineering |
| 04/07/1999 | EP0906340A1 Purification of factor viii complex by immunoaffinity chromatography |
| 04/07/1999 | EP0906339A2 Receptor and transporter antagonists |
| 04/07/1999 | EP0906338A1 Glucagon-like peptide-2 analogs |
| 04/07/1999 | EP0906337A2 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF |
| 04/07/1999 | EP0906335A1 Ebv ctl epitopes |
| 04/07/1999 | EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
| 04/07/1999 | EP0906328A1 Methods and compounds for curing diseases caused by mutations |
| 04/07/1999 | EP0906122A2 Activated linkers and methods for making and purifying the same |
| 04/07/1999 | EP0906119A1 Method of treatment |
| 04/07/1999 | EP0906019A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 04/07/1999 | EP0792458A4 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x- 41) and tau |
| 04/07/1999 | EP0754227A4 Chimeric complement inhibitor proteins |
| 04/07/1999 | EP0752884A4 Method of treating auto-immune diseases using type one interferons |
| 04/07/1999 | EP0734393B1 Method for purifying polypeptides |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | EP0642579B1 Improved methods for the preparation of endotoxin-binding proteins |
| 04/07/1999 | EP0625198B1 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 04/07/1999 | EP0625164B1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 04/07/1999 | EP0605586B1 Process for controlling lepidopteran pests |
| 04/07/1999 | EP0556214B1 Process for amplifying hla class i nucleic acid |
| 04/07/1999 | CN1213402A Recombinant expression of S-layer proteins |
| 04/07/1999 | CN1213401A Exodus chemokine materials and method |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/07/1999 | CN1213379A Peptide derivatives |
| 04/07/1999 | CN1213378A Antitumor substance extracted from Grifola |
| 04/07/1999 | CN1213326A Filtration of plasma mixtures using cellulose-based filter aids |
| 04/07/1999 | CN1212967A Parathormone related protein human source antibody and its preparation method |
| 04/07/1999 | CN1042833C Process for preparing growth factor of human nerve by embryonic down or decidual |
| 04/07/1999 | CA2249715A1 Abc transporter |
| 04/06/1999 | US5892018 Voltage independent, amiloride sensitive, sodium and lithium current, indiscriminant transport protein from human central nervous system; for diagnosis, gene therapy, and treatment of nervous system disorders |
| 04/06/1999 | US5892017 Recombinantly produced pf4ars are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. the antibodies are advantageously used in the prevention and treatment of |
| 04/06/1999 | US5892016 This invention relates to nucleic acid and amino acid sequences of a novel human tumor suppressor and to the use of these sequences in the diagnosis,prevention, and treatment of cancer and autoimmune diseases. |
| 04/06/1999 | US5892015 Human rhombotin-like protein |
| 04/06/1999 | US5892014 DNA encoding a protease-activated receptor 3 |
| 04/06/1999 | US5892010 Genes from the 20Q13 amplicon and their uses |
| 04/06/1999 | US5892009 DNA and encoded protein which regulates cold and dehydration regulated genes |
| 04/06/1999 | US5892005 High molecular and low molecular fractions of von willebrand factor |
| 04/06/1999 | US5892004 Method for preparing PACAP receptor protein |
| 04/06/1999 | US5892003 Ciliary neurotrophic factor receptor antibodies |
| 04/06/1999 | US5892001 Epithelium-derived T-cell factor antibodies |
| 04/06/1999 | US5891998 Interleukin-6 receptor agonists |
| 04/06/1999 | US5891997 Receptor for oncostatin M |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891992 Processes for affecting in various ways the metabolism of animals using such modified peptides and vaccines |
| 04/06/1999 | US5891991 Aplp1 and aplp2 are candidate genes for late onset familial alzheimer's disease. |
| 04/06/1999 | US5891859 Method for regulating cold and dehydration regulatory genes in a plant |
| 04/06/1999 | US5891857 Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
| 04/06/1999 | US5891850 Saccular collagen and compositions and methods for making and using the same |